{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:05:05Z","timestamp":1758935105497},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.cancergencyto.2005.08.003","type":"journal-article","created":{"date-parts":[[2006,5,7]],"date-time":"2006-05-07T11:12:53Z","timestamp":1147000373000},"page":"66-69","source":"Crossref","is-referenced-by-count":9,"title":["Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia"],"prefix":"10.1016","volume":"167","author":[{"given":"Brigitte","family":"Royer-Pokora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Trost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Germing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Beier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2005.08.003_bib1","first-page":"131","article-title":"The World Health Organization classification of acute leukemia and the myelodysplastic syndrome","volume":"72","author":"Bennett","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0145-2126(00)00088-6","article-title":"Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients","volume":"24","author":"Germing","year":"2000","journal-title":"Leukemia Res"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib3","series-title":"Tumours of haematopoetic and lymphoid tissues","article-title":"World Health Organization classification of tumours. pathology and genetics","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib4","first-page":"1315","article-title":"Cytogenetic analysis has a strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases","volume":"7","author":"Morel","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1046\/j.1365-2141.2003.04713.x","article-title":"Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes","volume":"123","author":"Stewart","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.leu.2403189","article-title":"Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31","volume":"18","author":"Giagounidis","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib7","series-title":"Cancer cytogenetics","author":"Heim","year":"1995"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib8","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1073\/pnas.92.16.7406","article-title":"Physical mapping of the minimal region of loss in 5q- chromosome","volume":"92","author":"Fairman","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib9","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood.V88.7.2665.bloodjournal8872665","article-title":"Polymerase chain reaction-based diagnosis of del(5q) in acute myeloid leukaemia and myelodysplastic syndrome identifies a minimal deletion interval","volume":"88","author":"Horrigan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib10","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1073\/pnas.94.13.6948","article-title":"Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map","volume":"94","author":"Zhao","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/geno.1994.1090","article-title":"Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint","volume":"19","author":"Boultwood","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0145-2126(03)00221-2","article-title":"Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics","volume":"28","author":"Trost","year":"2004","journal-title":"Leukemia Res"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib13","first-page":"310","article-title":"Molecular cytogenetics of stem cells: target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridisation of fluorescence-activated cell sorting","volume":"72","author":"Miura","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib14","first-page":"375","article-title":"Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridisation study on bone marrow smears","volume":"86","author":"Bigoni","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1035>3.0.CO;2-L","article-title":"Combined immunophenotyping and FISH identifies the involvement of B-cells ind 5q- syndrome","volume":"29","author":"Jaju","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2005.08.003_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa041668","article-title":"Efficacy of lenalidomide in myelodysplastic syndromes","volume":"352","author":"List","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805004553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805004553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T14:37:12Z","timestamp":1586875032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460805004553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0165460805004553"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2005.08.003","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}